Skip to the content

pharmaceutical daily

Pharmaceuticals, Biotechnology and Life Sciences

  • HOME
  • Pharma Business
  • About us
    • Media Kit
    • Privacy Policy
  • Contact
November 7, 2019 Off

Spectrum Pharmaceuticals Reports Third Quarter 2019 Financial Results and Pipeline Update

By BusinessWire

Topline data from Cohort 1 of ZENITH20 trial evaluating poziotinib for NSCLC expected in December Basket trial initiated to study…

November 7, 2019 Off

AmeriHealth Caritas Encourages People of Color, Especially Children and Teens, to Get Flu Shots Following Longest Flu Season in a Decade

By BusinessWire

Getting vaccinated in the fall could offer better protection for the coming winter PHILADELPHIA–(BUSINESS WIRE)–#AmeriHealthCaritas–The Influenza virus, more commonly known…

November 7, 2019 Off

AmeriHealth Caritas Encourages People of Color, Especially Children and Teens, to Get Flu Shots Following Longest Flu Season in a Decade

By BusinessWire

Getting vaccinated in the fall could offer better protection for the coming winter PHILADELPHIA–(BUSINESS WIRE)–#AmeriHealthCaritas–The Influenza virus, more commonly known…

November 7, 2019 Off

ClinOne and Boston Children’s Hospital Team Up, Enhance How Patients Consent into Clinical Trials

By BusinessWire

DENVER–(BUSINESS WIRE)–#clinicaltrials–This summer, ClinOne and Boston Children’s Hospital (BCH) launched ClinOne’s eConsent with Video eConsent technology within Boston Children’s Pulmonary…

November 7, 2019 Off

DermTech, Inc. Reports Third Quarter 2019 Financial Results and Provides Corporate Update

By BusinessWire

LA JOLLA, Calif.–(BUSINESS WIRE)–DermTech, Inc. (NASDAQ: DMTK) (“DermTech” or the “Company”), a leader in precision dermatology enabled by a non-invasive…

November 7, 2019 Off

AvantGen Enters a Strategic Collaboration Agreement to Develop Novel Anti-Cancer Therapeutic With Its NK Cell Engager Technology

By BusinessWire

AvantGen’s NK cell engager technology now available for partnering on a target-exclusive basis SAN DIEGO–(BUSINESS WIRE)–AvantGen, Inc., a biotechnology company…

November 7, 2019 Off

Talaris Therapeutics Presents Data Supporting Potential of FCR001 to Prevent Recurrence of Kidney-Related Autoimmune Disease in Kidney Transplant Recipients

By BusinessWire

BOSTON & LOUISVILLE, Ky.–(BUSINESS WIRE)–Talaris Therapeutics, Inc., a privately held biotechnology company developing transformative cell therapies that have the potential…

November 7, 2019 Off

Targos and Ultivue Partner to Incorporate Highly Standardized UltiMapper™ Tissue Multiplex Phenotypic Assays in Support of Clinical Research Services

By BusinessWire

KASSEL, Germany & CAMBRIDGE, Mass.–(BUSINESS WIRE)–Targos Molecular Pathology GmbH, a market leader in clinical biomarker services announced today a technology…

November 7, 2019 Off

South Korean Company, Yuhan Pharmaceuticals Partners with Cyclica to Advance R&D Across Two Separate Programs for Oncology

By BusinessWire

TORONTO & SEOUL, South Korea–(BUSINESS WIRE)–#artificialintelligence–Renowned South Korean healthcare company, Yuhan Pharmaceuticals (Yuhan) and Cyclica Inc. (Cyclica), a leading neo…

November 7, 2019 Off

AbCellera Announces the Issuance of Foundational Patent Claims Around Microfluidic Screening Assays for Antibody Discovery

By BusinessWire

VANCOUVER, British Columbia–(BUSINESS WIRE)–#antibodies–AbCellera Biologics Inc., a global leader in therapeutic antibody discovery from natural immune systems, today announced that…

Posts pagination

Previous 1 … 5,354 5,355 5,356 … 6,212 Next

Popular posts

Medicago, GSK report primary and secondary endpoints with available data met in trial dominated by COVID-19 variants

December 10, 2021 Off

Celltrion receives positive CHMP Opinion for SteQeyma™ (ustekinumab biosimilar) autoinjector

December 18, 2025 Off
Cosentyx meets the primary endpoints

Cosentyx meets the primary endpoints

June 15, 2015 Off
Adapt Pharma rolls submision to NDA for naloxone-based nasal spray

Adapt Pharma rolls submision to NDA for naloxone-based nasal spray

June 15, 2015 Off
Strensiq in HPP patiens therapy get approval from European Commission

Strensiq in HPP patiens therapy get approval from European Commission

September 13, 2015 Off

JOIN OUR COMMUNITY

Proudly powered by WordPress | Theme: Envo Magazine